These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1336061)

  • 1. Decrease in beta 1- and increase in beta 2-adrenoceptors in long-term follow-up after orthotopic cardiac transplantation.
    Steinfath M; von der Leyen H; Hecht A; Neumann KH; Schmitz W; Scholz H; Haverich A; Heublein B
    J Mol Cell Cardiol; 1992 Oct; 24(10):1189-98. PubMed ID: 1336061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenoceptors in the transplanted human heart: unaltered beta-adrenoceptor density, but increased proportion of beta 2-adrenoceptors with increasing posttransplant time.
    Brodde OE; Khamssi M; Zerkowski HR
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):430-6. PubMed ID: 1685012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of beta-adrenoceptor number and subtype distribution in the transplanted human heart.
    Zerkowski HR; Khamssi M; Brodde OE
    Eur Heart J; 1991 Dec; 12 Suppl F():124-6. PubMed ID: 1666551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of orthotopic transplantation on total, beta 1- and beta 2-adrenoceptors in the human heart.
    Chester MR; Madden B; Barnett D; Yacoub M
    Br J Clin Pharmacol; 1992 Apr; 33(4):417-22. PubMed ID: 1315563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional distribution of beta-adrenoceptors in the human heart: coexistence of functional beta 1- and beta 2-adrenoceptors in both atria and ventricles in severe congestive cardiomyopathy.
    Brodde OE; Schüler S; Kretsch R; Brinkmann M; Borst HG; Hetzer R; Reidemeister JC; Warnecke H; Zerkowski HR
    J Cardiovasc Pharmacol; 1986; 8(6):1235-42. PubMed ID: 2434752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of beta-adrenoceptor subtype on rat isolated ventricular myocytes by use of highly selective beta-antagonists.
    Kitagawa Y; Adachi-Akahane S; Nagao T
    Br J Pharmacol; 1995 Sep; 116(1):1635-43. PubMed ID: 8564230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.
    Schumacher C; Becker H; Conrads R; Schotten U; Pott S; Kellinghaus M; Sigmund M; Schöndube F; Preusse C; Schulte HD
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):398-407. PubMed ID: 7630430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cardiac beta-adrenoceptors in human heart diseases: relationship to the degree of heart failure and further evidence for etiology-related regulation of beta 1 and beta 2 subtypes.
    Steinfath M; Lavicky J; Schmitz W; Scholz H; Döring V; Kalmár P
    J Cardiothorac Vasc Anesth; 1993 Dec; 7(6):668-73. PubMed ID: 7905755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte beta 2-adrenoceptors mirror precisely beta 2-adrenoceptor, but poorly beta 1-adrenoceptor changes in the human heart.
    Michel MC; Beckeringh JJ; Ikezono K; Kretsch R; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S215-8. PubMed ID: 2886571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
    Bjørnerheim R; Golf S; Hansson V
    Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoradiographic localization and quantitation of beta 1- and beta 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease.
    Elnatan J; Molenaar P; Rosenfeldt FL; Summers RJ
    J Mol Cell Cardiol; 1994 Mar; 26(3):313-23. PubMed ID: 7913135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial beta-adrenoceptor density and the distribution of beta 1- and beta 2-adrenoceptor subpopulations in children with congenital heart disease.
    Kozlik R; Kramer HH; Wicht H; Krian A; Ostermeyer J; Reinhardt D
    Eur J Pediatr; 1991 Apr; 150(6):388-94. PubMed ID: 1645667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
    Nanoff C; Freissmuth M; Schütz W
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial beta-adrenoceptors and inhibitory G-proteins in myocardial biopsies and in explanted hearts from patients with dilated cardiomyopathy.
    Böhm M; Gierschik P; Schnabel P; Erdmann E
    Cardioscience; 1990 Jun; 1(2):109-17. PubMed ID: 1966374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta adrenoceptor density in the donor heart: a guide to prognosis?
    Chester MR; Amadi AA; Barnett DB
    Br Heart J; 1995 Jun; 73(6):540-3. PubMed ID: 7626353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between simvastatin and metoprolol with respect to cardiac beta-adrenoceptor density, catecholamine levels and perioperative catecholamine requirements in cardiac surgery patients.
    Nette AF; Abraham G; Ungemach FR; Oertel R; Kirch W; Leineweber K; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):115-24. PubMed ID: 16215713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-homogeneous distribution of beta 1- and beta 2-adrenoceptors in various human tissues.
    Sano M; Yoshimasa T; Yagura T; Yamamoto I
    Life Sci; 1993; 52(12):1063-70. PubMed ID: 8383268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.
    Buxton BF; Jones CR; Molenaar P; Summers RJ
    Br J Pharmacol; 1987 Oct; 92(2):299-310. PubMed ID: 2823947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic pindolol treatment on human myocardial beta 1- and beta 2-adrenoceptor function.
    Bjørnerheim R; Golf S; Hansson V
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Oct; 342(4):429-35. PubMed ID: 2175014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
    Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
    Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.